Shahinaz Gadalla

"Transplantation has definitely improved with time, but still a lot of patients die after this procedure. We still have an average five year survival after these procedures of 50 or 60 percent, so we still have a lot to do."

"Even being in medicine, you don’t know all the ins and outs, but I saw it from the other direction."

"We think that this research will probably introduce a paradigm shift in donor selection. This can help get us away from the idea of chronological age and towards building a set of molecular markers that can define the cellular age of a donor."

"The beauty of this data is we can look for molecular signatures for better donor selection and build personalized risk calculators for recipients. We want to tailor treatment to the particular patient."